Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Training Methods Could Reduce Bias In Artificial Intelligence

Executive Summary

A “federated” training method could be used to reduce bias in AI, according to one expert on patient safety.

You may also be interested in...



Northwell Health And Aegis Ventures Form An Artificial Intelligence Joint Venture

The New York-based health system and the start-up “studio” plan to create AI-driven companies to address quality, equity, and cost problems in health care.

Minute Insight: Hedera DX Completes €14m Raise To Fund ML-Backed Liquid Biopsy Tech

Hedera DX’s liquid biopsy test uses machine learning to recommend drugs to patients based on a tumor’s circulating DNA profile.

Minute Insight: Aignostics Completes Raise To Fund AI Pathology Platform

The company has raised €14m to develop its AI-based pathology software which will make diagnosing cancer faster and easier.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT143904

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel